In the published article, there was an error in Table 2, “Comparison of the days of common symptoms in infants and young children during the intervention period” as published.
The positions of “IG” and “CG” in the column headings were erroneously swapped. Similarly, “44 0.89” and “99 2.2” in the “Fever” row were incorrectly switched.
The corrected Table 2 appears below.
Table 2
| Common symptoms | CG (N = 50) | IG (N = 50) | p-value | ||
|---|---|---|---|---|---|
| Total occurrence days | Incident rate per 100 intervention days (%)† | Total occurrence days | Incident rate per 100 intervention days (%)† | ||
| Cough* | 190 | 4.22 | 99 | 2.2 | < 0.001 |
| Runny nose | 171 | 3.8 | 136 | 3.02 | 0.133 |
| Stuffy nose | 120 | 2.67 | 83 | 1.84 | 0.066 |
| Fever* | 99 | 2.2 | 40 | 0.89 | < 0.001 |
| Loose stools | 97 | 2.16 | 120 | 2.67 | 0.413 |
| Increased frequency of bowel movements | 105 | 2.33 | 105 | 2.33 | 0.921 |
| Colic of the intestines | 105 | 2.33 | 102 | 2.27 | 0.979 |
| Dry stool* | 346 | 7.69 | 157 | 3.49 | 0.012 |
| Choking | 45 | 1 | 58 | 1.29 | 0.387 |
| Increased belching/bloating/anal gas | 87 | 1.93 | 89 | 1.98 | 0.915 |
| Retching/vomiting | 35 | 0.78 | 52 | 1.16 | 0.244 |
| Stool with milk flaps/food residues/sour odor | 183 | 4.07 | 194 | 4.31 | 0.867 |
| Reflux | 58 | 1.29 | 64 | 1.42 | 0.393 |
| Decreased appetite | 181 | 4.02 | 135 | 3 | 0.285 |
| Dysphoria | 225 | 5 | 151 | 3.36 | 0.659 |
| Refusal to eat | 83 | 1.84 | 145 | 3.22 | 0.065 |
| Eczematous changes of the skin* | 578 | 12.84 | 134 | 2.98 | 0.002 |
| Erythematous changes in the skin | 12 | 0.27 | 9 | 0.2 | 0.958 |
| Skin wheal-like changes | 10 | 0.22 | 7 | 0.16 | 0.552 |
Comparison of the days of common symptoms in infants and young children during the intervention period.
†A total of 9,000 study days (calculated method: 180 days × 50 people). Symptom incidence per 100 intervention days = duration of a symptom/total intervention days × 100%.
*Mann–Whitney U-test for two independent samples, p-values < 0.01. Dry stool refers to stool Bristol score type 1–3 stool.
IG, intervention group; CG, control group.
The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
probiotics, short chain fatty acids, children, gut microbiota, upper respiratory tract infection
Citation
Zhang X, Chen K, Lan H, Chen H, Chen H, Yang P, He N, Hung W, Zeng Z and Liu C (2025) Correction: Effect of Bifidobacterium longum subsp. infantis YLGB-1496 on common diseases in pediatrics: a randomized, blinded, placebo-controlled trial. Front. Nutr. 12:1661669. doi: 10.3389/fnut.2025.1661669
Received
08 July 2025
Accepted
22 July 2025
Published
04 August 2025
Volume
12 - 2025
Edited and reviewed by
Michael J. Barratt, Washington University in St. Louis, United States
Updates
Copyright
© 2025 Zhang, Chen, Lan, Chen, Chen, Yang, He, Hung, Zeng and Liu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ke Chen kechen@uestc.edu.cn
†These authors share first authorship
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.